Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
Carmell Corporation (Nasdaq: CTCX), today announced the addition of two independent directors to their Board.
Carmell Corporation (Nasdaq: CTCX), a regenerative care company, today announced the completion of post-merger integration with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company.
Carmell Corporation (Nasdaq: CTCX), a regenerative care company today announced the successful closing of the previously announced merger with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company.
Carmell Therapeutics Corporation (Nasdaq: CTCX), a regenerative medicine company today announced the execution of a definitive agreement and plan of merger with Flagstaff-based Axolotl Biologix.